The FDA approved pembrolizumab (Keytruda) or pembrolizumab and berahyaluronidase alfa (Keytruda Qlex) in combination with ...

AMHERST, Mass. (WWLP) – A University of Massachusetts Amherst research team has been awarded up to $3.45 million from the National Institutes of Health to help develop a new way to prevent the ...

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced ...

USA: A new systematic review published in the Cochrane Database of Systematic Reviews suggests that blue light-enhanced ...

Researchers found that mRNA cancer vaccines can recruit an unexpected immune cell to launch powerful tumor-fighting responses ...

The increasingly more popular combination of Padcev and Keytruda has expanded its bladder cancer territory once again. | The ...

In late June 2026, Merck reported multiple oncology milestones, including U.S. FDA approval of KEYTRUDA and KEYTRUDA QLEX ...

Bladder cancer continues to be one of the most frequently diagnosed malignancies worldwide, with current treatments such as surgery and chemotherapy often ...

University of Colorado football coach Deion Sanders says he feels like his younger self again after undergoing surgery to ...

Adults diagnosed with muscle-invasive bladder cancer gained a new treatment option on July 10, 2026, when the FDA cleared the ...

FDA clearance enables initiation of a planned Phase 1 clinical study evaluating local intravesical administration of UGN-501, with patient ...

A new treatment combination - Keytruda plus Padcev - is now approved for use before and after bladder‑removal surgery, ...